/C O R R E C T I O N -- Pfizer Ltd/.

PR Newswire Europe, May, 2007

LONDON, May 30 /PRNewswire/ -- In the news release, "NICE Recommends Champixq(R) (Varenicline tartrate) for Smokers Who Want to Stop" issued on 30 May 2007 09:00 GMT, by Pfizer Ltd Bloomberg:PFE@GR over PR Newswire, we are advised by a representative of the company that the correct name of the drug is Champix(R), and not Champixq(R) as incorrectly transmitted in the headline by PR Newswire. Complete, corrected release follows:

- Smokers Right Across the UK Should Now Have Access to New Stop Smoking Medicine

Less than five weeks before England goes smokefree, Champix(R) (varenicline tartrate) has been recommended for use on the NHS by the National Institute for Health and Clinical Excellence (NICE) as an option for adult smokers who have expressed a...

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement